News

Localization of Therapeutic Fab-CHP Conjugates to Sites of Denatured Collagen for the Treatment of Rheumatoid Arthritis

Anthony Kolton 0 Comments

In a recently accepted article published in Bioconjugate Chemistry, researchers from the University of Utah used CHPs in an antibody-conjugate to address Rheumatoid Arthritis(RA). In this paper, the authors used the Fab region from infliximab (an anti-TNFα therapy known as Remicade®) and conjugated this with CHPs. Figure Caption.  A) Biodistribution of IR680 labeled bFab-(NIRF)CHP...
View Details

3Helix Welcomes Three new Team Members!

Anthony Kolton 0 Comments

3Helix is thrilled to announce the addition of three new members to our talented team.  These new members bring with them experience and expertise that will contribute to our continued success. It is our pleasure to introduce Regan, Keelah, and Anthony to you all. Please help us congratulate them on joining our team! We...
View Details

Effective enzymatic debridement of burn wounds depends on the denaturation status of collagen

Anthony Kolton 0 Comments

Another great paper using CHPs! A recent article published in Wound Repair and Regeneration evaluated how the level of collagen denaturation within burned tissues influences the effectiveness of enzymatic debridement (removal of damaged tissue). They showed that low-temperature burns (<65 °C) had inadequate debridement, while high-temperature burns (>65 °C) had very effective debridement. By...
View Details